Analyzing the Latest Data for Gonadotropin-Releasing Hormone Agonists and Antagonists in Prostate Cancer: What Does This Mean for the Patient?

episode

Keeping Current CME not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Biggest Criticism Of Taylor Swift Debunked & The Secret Messages Behind Her New Songs 52 min · 28 Sep 2026 · The Spill

NPR News: 09-28-2026 1AM EDT 5 min · 28 Sep 2026 · NPR News Now

The Jerker Episode 54 min · 28 Sep 2026 · Distractible

1AM ET 09/28/2026 Newscast 3 min · 28 Sep 2026 · Fox News Hourly Update

"TEARS OF JOY!" | Brave Knights Stun World to Book GF vs Roosters 2h 21m · 28 Sep 2026 · Bloke In A Bar

Take Heed How You Hear 5 min · 28 Sep 2026 · Things Unseen with Sinclair B. Ferguson

Report any issue

Source

Recorded19 Mar 2024

Publisherkeepingcurrentcme.libsyn.com ↗

Handlerec:4299734

Show notes

Why does it really matter which GnRH agonist or antagonist you choose for your patient, and how can you use the latest data to inform this decision? Credit available for this activity expires: 3/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000411?ecd=bdc_podcast_libsyn_mscpedu

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in